UNSPSC 51342100: Antiviral benzimidazoles

Antiviral drugs made from compounds with a benzene fused to imidazoles.

UNSPSC 51342100 Antiviral benzimidazoles, a Class code, does not align with state and local procurement activity recently posted under this classification. The code nominally covers specific antiviral pharmaceutical compounds, yet the recent opportunities tagged to it span naloxone procurement, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceutical and OTC product contracting through cooperative purchasing. None of these solicitations reference benzimidazole antivirals or related compound families; the mismatch suggests either a classification error in the source data or that this code captures pharmaceutical procurement activity at such a broad administrative level that state and local agencies apply it without regard to specific drug classes. State and local governments do procure pharmaceutical products through formal competitive bidding, but the recent opportunities indicate that activity concentrates on naloxone and emergency-response medical supplies, generic pharmaceuticals through state and cooperative purchasing agreements, and pharmacy benefit program administration rather than on antiviral benzimidazole compounds specifically.

The issuing bodies include Seminole County, Florida (health department procurement), the City of Tampa (fire rescue supplies through an SLBE-sheltered bid), Texas Health and Human Services Commission (pharmacy benefit market research), and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving multiple state and local jurisdictions across Minnesota and Oregon. Geographic activity appears in Florida, Texas, and the upper Midwest through cooperative purchasing, though the code shows no clear pattern of demand for benzimidazole antivirals themselves. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries, the City of Tampa's medical and first aid supplies IFB 26P00145 (posted March 25, 2026, due March 13, 2026) with an estimated value of $700,000.00 and SLBE set-aside designation, and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic pharmaceuticals and OTC products. The code shows little relevant recent activity tied to antiviral benzimidazoles as a distinct procurement line.